Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Balza

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Cell Biology|March 1, 1989
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursorsB Carnemolla, E Balza, A Siri, et al.
Cell Death & Disease|July 22, 2016
Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-toleranceE Balza, P Piccioli, S Carta, et al.
Blood|June 25, 1999
A high-affinity human antibody that targets tumoral blood vesselsL Tarli, E Balza, F Viti, et al.
Cancer|December 24, 1997
Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implantsG Mariani, A Lasku, E Balza, et al.
Nature Biotechnology|November 14, 1997
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformD Neri, B Carnemolla, A Nissim, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Cell Biology|March 1, 1989
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursorsB Carnemolla, E Balza, A Siri, et al.
Cell Death & Disease|July 22, 2016
Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-toleranceE Balza, P Piccioli, S Carta, et al.
Blood|June 25, 1999
A high-affinity human antibody that targets tumoral blood vesselsL Tarli, E Balza, F Viti, et al.
Cancer|December 24, 1997
Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implantsG Mariani, A Lasku, E Balza, et al.
Nature Biotechnology|November 14, 1997
Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformD Neri, B Carnemolla, A Nissim, et al.
Pageof 3